Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMC 297454)

Published in J Clin Invest on November 01, 1969

Authors

A D Jose, R R Taylor

Articles citing this

Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J Clin Invest (1990) 1.29

Nonlinear-dynamical arrhythmia control in humans. Proc Natl Acad Sci U S A (2001) 1.14

Mechanism of blood pressure and R-R variability: insights from ganglion blockade in humans. J Physiol (2002) 1.06

Beta-adrenergic or parasympathetic inhibition, heart rate and cardiac output during normoxic and acute hypoxic exercise in humans. J Physiol (2003) 1.04

Adaptation of the human carotid baroreceptor-cardiac reflex. J Physiol (1977) 1.04

Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest (1972) 1.03

Influence of dihydralazine induced afterload reduction on systolic time intervals and echocardiography in healthy subjects. Br Heart J (1984) 0.98

Baroreflex control of stroke volume in man: an effect mediated by the vagus. J Physiol (1992) 0.93

Relative contribution of aortic and carotid baroreflexes to heart rate control in man during steady state and dynamic increases in arterial pressure. J Clin Invest (1985) 0.92

Impaired cardiac muscarinic receptor function in dogs with heart failure. J Clin Invest (1988) 0.88

Parasympathetic withdrawal increases heart rate after two weeks at 3,454 m altitude. J Physiol (2016) 0.85

Baroreflex sensitivity and cardiopulmonary blood volume in normotensive and hypertensive patients. Br Heart J (1977) 0.83

Autonomic effects on the human cardiac conduction system. Evaluation by intracardiac electrocardiography and programmed stimulation techniques. Br Heart J (1980) 0.82

Role of central blood volume in hyperkinetic borderline hypertension. Br Heart J (1973) 0.81

Characterisation of heart rate response to exercise in the sick sinus syndrome. Br Heart J (1978) 0.80

Effects of atropine on left ventricular volumes and ejection and filling rates at rest and during exercise. Br J Clin Pharmacol (1991) 0.78

Limitations of facial immersion as a test of parasympathetic activity in man. J Physiol (1988) 0.78

Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias. J Clin Invest (1988) 0.78

Vagal control of heart rate variability in vasovagal syncope: studies based on 24-h electrocardiogram recordings. Clin Auton Res (1997) 0.78

Heart rate variability and sympathovagal balance: pharmacological validation. Neth Heart J (2003) 0.76

Effect of digoxin on the heart in normal subjects: influence of isometric exercise and autonomic blockade: a noninvasive study. Br J Clin Pharmacol (1988) 0.75

Effects of alpha-adrenoceptor and of combined sympathetic and parasympathetic blockade on cardiac performance and vascular resistance. Br J Clin Pharmacol (1992) 0.75

Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway. Pacing Clin Electrophysiol (2016) 0.75

Predominance of Intrinsic Mechanism of Resting Heart Rate Control and Preserved Baroreflex Sensitivity in Professional Cyclists after Competitive Training. PLoS One (2016) 0.75

Comparison of the physiologic and prognostic implications of the heart rate versus the RR interval. Heart Rhythm (2014) 0.75

Autonomic effects of exercise-based cardiac rehabilitation. J Cardiopulm Rehabil Prev (2011) 0.75

Effect of parasympathetic impairment on the haemodynamic response to handgrip in Chagas's heart disease. Br Heart J (1986) 0.75

Proceedings: Fractionation and assay of chicken porlactin. J Physiol (1974) 0.75

Subacute pyridostigmine exposure increases heart rate recovery and cardiac parasympathetic tone in rats. Clin Exp Pharmacol Physiol (2017) 0.75

Pharmacological probes to measure the importance of the autonomic nervous system. Clin Auton Res (2007) 0.75

Articles cited by this

Effects of atropine on heart-rate in healthy man. Lancet (1967) 5.10

Unwanted effects of propranolol. Am J Cardiol (1966) 4.33

The pharmacology of beta sympathetic blockade. Am J Cardiol (1966) 3.96

Control of heart rate by the autonomic nervous system. Studies in man on the interrelation between baroreceptor mechanisms and exercise. Circ Res (1966) 3.95

Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol (1966) 3.77

The effect of propranolol on the cardiovascular responses to isoprenaline, adrenaline and noradrenaline in the anaesthetized dog. Br J Pharmacol Chemother (1966) 2.52

The dynamics of both right and left ventricles at rest and during exercise in patients with heart failure. Circ Res (1953) 1.99

THE STUDY OF LEFT VENTRICULAR FUNCTION IN MAN BY INCREASING RESISTANCE TO VENTRICULAR EJECTION WITH ANGIOTENSIN. Circulation (1964) 1.53

The effect of exercise on mean left ventricular ejection rate in man. J Clin Invest (1962) 1.32

The actions of metabolic substrates and inhibitors on the rabbit auricle. Br J Pharmacol Chemother (1950) 1.31

Atropine, scopolamine, and related compounds. Anesthesiology (1962) 1.11

The response of the abnormal heart to exercise. Circulation (1962) 1.10

The action of some enzyme inhibitors on the isolated rabbit auricle. J Pharmacol Exp Ther (1954) 1.00

The value of injections of dye into the left heart in the study of mitral and aortic valvular disease by catheterization of the left heart. Am Heart J (1960) 0.98

STUDIES ON THE FUNCTION OF THE ADRENERGIC NERVE ENDINGS IN THE HEART. Circulation (1963) 0.97

Effects of hypoxia and metabolic inhibitors on the intrinsic heart rate and myocardial contractility in dogs. Circ Res (1969) 0.85

Articles by these authors

(truncated to the top 100)

A community-based study of chronic fatigue syndrome. Arch Intern Med (1999) 6.04

Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am J Cardiol (1966) 3.77

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation (1997) 2.80

Platelet and plasma platelet-activating factor in sepsis and myocardial infarction. J Lipid Mediat Cell Signal (1994) 2.07

Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK. J Wound Care (2012) 2.06

Improved analysis of brachial artery ultrasound using a novel edge-detection software system. J Appl Physiol (1985) (2001) 2.02

The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res (1970) 1.77

Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation (1997) 1.64

Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection. J Antimicrob Chemother (1998) 1.60

Dependence of ventricular distensibility on filling of the opposite ventricle. Am J Physiol (1967) 1.33

Diastolic geometry and sarcomere lengths in the chronically dilated canine left ventricle. Circ Res (1971) 1.32

Left ventricular function in experimental aorto-caval fistula with circulatory congestion and fluid retention. J Clin Invest (1968) 1.22

Modification of forearm resistance vessels by exercise training in young men. J Appl Physiol (1985) (1994) 1.21

Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer (2001) 1.16

Chronic fatigue syndrome: occupation, medical utilization, and subtypes in a community-based sample. J Nerv Ment Dis (2000) 1.16

Congestive heart failure following chronic tachycardia. Am Heart J (1971) 1.15

Regression of left ventricular dilation and hypertrophy after removal of volume overload. Morphological and ultrastructural study. Circ Res (1974) 1.12

Influence of the thyroid state on left ventricular tension-velocity relations in the intact, sedated dog. J Clin Invest (1969) 1.12

The effects of exercise and changes in body temperature on the intrinsic heart rate in man. Am Heart J (1970) 1.11

Control of skeletal muscle blood flow during dynamic exercise: contribution of endothelium-derived nitric oxide. Sports Med (1996) 1.09

A quantitative analysis of left ventricular myocardial function in the intact, sedated dog. Circ Res (1967) 1.09

Endothelium-derived nitric oxide activity in forearm vessels of tennis players. J Appl Physiol (1985) (1996) 1.08

Differential antibody recognition of FC27-like Plasmodium falciparum merozoite surface protein MSP2 antigens which lack 12 amino acid repeats. Parasite Immunol (1996) 1.05

Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med (2001) 1.04

Biochemical diversity within the "Mycoplasma mycoides" cluster. Microbiology (1994) 1.03

Efficacy of the latest fluoroquinolones against experimental Yersinia pestis. Int J Antimicrob Agents (2004) 1.03

Evaluation of irinotecan drug-eluting beads: a new drug-device combination product for the chemoembolization of hepatic metastases. J Control Release (2006) 1.02

Oxygen uptake and H2O2 production by fermentative Mycoplasma spp. J Med Microbiol (1991) 1.02

Measurement of myocardial developed tension and its relation to oxygen consumption. Am J Physiol (1966) 1.00

Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med (1994) 1.00

Physical factors and cardiac adaptation. Am J Physiol (1966) 0.98

Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk (2001) 0.97

Collision of uterine rhabdoid tumor and endometrioid adenocarcinoma: a case report and review of the literature. Int J Gynecol Pathol (1999) 0.95

Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects. Clin Exp Pharmacol Physiol (1999) 0.95

Chronic fatigue syndrome: sociodemographic subtypes in a community-based sample. Eval Health Prof (2000) 0.95

Comparison of the LDL-receptor binding of VLDL and LDL from apoE4 and apoE3 homozygotes. Am J Physiol (1999) 0.95

Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol (1997) 0.94

Volume-tension diagrams of ejecting and isovolumic contractions in left ventricle. Am J Physiol (1969) 0.92

Symptom occurrence in persons with chronic fatigue syndrome. Biol Psychol (2002) 0.92

Active length-tension relations compared in isometric, afterloaded and isotonic contractions of cat papillary muscle. Their dependence on inotropic state. Circ Res (1970) 0.90

Attitudes regarding chronic fatigue syndrome: the importance of a name. J Health Psychol (2001) 0.90

Monitoring and assessing symptoms of chronic fatigue syndrome: use of time series regression. Psychol Rep (1999) 0.90

Assessing attitudes toward new names for chronic fatigue syndrome. Eval Health Prof (2001) 0.90

Effect of beta-adrenergic blockade on the results of exercise testing related to the extent of coronary artery disease. Am J Cardiol (1985) 0.89

Primary angiosarcoma of the ovary: a case report and review of the literature. Gynecol Oncol (1999) 0.88

Effects of chelation with EDTA and vitamin B therapy on nitric oxide-related endothelial vasodilator function. Clin Exp Pharmacol Physiol (1999) 0.88

The series elasticity of cardiac muscle in hyperthyroidism, ventricular hypertrophy, and heart failure. Proc Soc Exp Biol Med (1968) 0.88

A national assessment of the service, support, and housing preferences by persons with chronic fatigue syndrome. Toward a comprehensive rehabilitation program. Eval Health Prof (1996) 0.87

Theoretical analysis of the isovolumic phase of left ventricular contraction in terms of cardiac muscle mechanics. Cardiovasc Res (1970) 0.87

Feminist perspectives on the social construction of chronic fatigue syndrome. Health Care Women Int (2001) 0.86

Protein synthesis during right-ventricular hypertrophy after pulmonary-artery stenosis in the dog. Biochem J (1977) 0.86

Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation. Br Heart J (1980) 0.86

The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle. Atherosclerosis (1998) 0.85

Effects of hypoxia and metabolic inhibitors on the intrinsic heart rate and myocardial contractility in dogs. Circ Res (1969) 0.85

Molecular characterization of adenocarcinoma of the cervix. Gynecol Oncol (1997) 0.85

Relationships between left ventricular volume, ejected fraction, and wall stress. Am J Physiol (1966) 0.85

Contractile properties of cardiac muscle in hyperthyroidism. Analysis of behavior of hyperthyroid cat papillary muscle in vitro relevant to thyrotoxic heart disease. Circ Res (1970) 0.85

Chronic fatigue syndrome: an examination of the phases. J Clin Psychol (2000) 0.85

Influence of sodium bicarbonate on myocardial performance. Am J Physiol (1967) 0.85

Early changes in myocardial protein synthesis in vivo in response to right ventricular pressure overload in the dog. J Mol Cell Cardiol (1979) 0.85

Cystoscopy after computed tomography scan to identify bladder invasion in cervical cancer. Obstet Gynecol (1998) 0.84

Cigarette smoking and ventricular arrhythmia in coronary heart disease. Am J Cardiol (1984) 0.84

Platelet-activating factor and lipid metabolism in acute malaria. J Infect (1993) 0.84

Beta-adrenergic blockade in the treatment of exercise-induced paroxysmal ventricular tachycardia. Circulation (1965) 0.83

Myocardial digoxin uptake in pressure overload right ventricular hypertrophy. Cardiovasc Res (1974) 0.83

Developmental analysis and computer modelling of bioengineered teeth. Arch Oral Biol (2005) 0.83

Premature ischaemic heart disease and the gene for coagulation factor V. Nat Med (1995) 0.83

Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty. Circulation (1995) 0.83

Costs and outcomes over 36 years of patients with phenylketonuria who do and do not remain on a phenylalanine-restricted diet. J Intellect Disabil Res (2012) 0.82

Influence of various catecholamines on aortic regurgitation. J Appl Physiol (1973) 0.82

Influence of myocardial mechanical activity and coronary blood flow on myocardial digoxin uptake. Cardiovasc Res (1976) 0.81

Age dependence of myocardial Na+-K+-ATPase activity and digitalis intoxication in the dog and guinea pig. Circ Res (1981) 0.81

Effect of casting on forearm resistance vessels in young men. Med Sci Sports Exerc (1997) 0.80

The effect of heart rate on myocardial ouabain uptake and on the susceptibility to ouabain cardiotoxicity in the dog. Clin Exp Pharmacol Physiol (1978) 0.80

p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma. Gynecol Oncol (2000) 0.80

Digitalis-induced increase in aortic regurgitation and the contrasting effect of glucagon in the sedated dog. J Clin Invest (1974) 0.80

Apolipoprotein epsilon 4 homozygosity--a determinant of restenosis after coronary angioplasty. Atherosclerosis (1994) 0.80

PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty. Am J Cardiol (1998) 0.80

The measurement of plasma thromboxane B2 and the effect of smoking. Clin Exp Pharmacol Physiol (1985) 0.80

Familial hypertrophic cariomyopathy and lentiginosis. Aust N Z J Med (1975) 0.79

Effect of chronic circulatory volume overload on digitalis intoxication. Cardiovasc Res (1973) 0.79

Analysis of blood carbon monoxide and oxygen by gas chromatography. J Appl Physiol (1967) 0.79

Beneficial effect of vitamin E administration on nitric oxide function in subjects with hypercholesterolaemia. Clin Sci (Lond) (1998) 0.79

Hypoxemia after gastric bypass surgery for morbid obesity. Arch Surg (1985) 0.79

Plasma phospholipase A2 activity in clinical acute myocardial infarction. Clin Exp Pharmacol Physiol (1992) 0.79

Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction. Coron Artery Dis (1993) 0.78

Alopecia areata regrowth induced by Primula obconica. Br J Dermatol (1981) 0.78

Digoxin distribution in the dog's left ventricle in the presence of coronary artery ligation. J Mol Cell Cardiol (1973) 0.78

Influence of respiration and respiratory sinus arrhythmia on aortic regurgitation. Am J Physiol (1972) 0.78

A community-based study of seasonal variation in the onset of chronic fatigue syndrome and idiopathic chronic fatigue. Chronobiol Int (2001) 0.78

Whole blood aggregation, thromboxane release and the lyso derivative of platelet activating factor in myocardial infarction and unstable angina. Cardiovasc Res (1989) 0.77

Increased protein synthesis and degradation in the dog heart during thyroxine administration. J Mol Cell Cardiol (1983) 0.77

Left ventricular response to experimentally induced chronic aortic regurgitation. Cardiovasc Res (1972) 0.77

Cardiac beta-adrenoreceptors in the thyroxine-treated dog. Clin Exp Pharmacol Physiol (1981) 0.77

Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery. Cardiovasc Res (1992) 0.77

Functional somatic syndromes. Lancet (1999) 0.77

No association between the 20210 G/A prothrombin gene mutation and premature coronary artery disease. Thromb Haemost (1998) 0.77

Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency. Med J Aust (1993) 0.77

Randomized controlled trial of vasodilator therapy after myocardial infarction. Am J Cardiol (1981) 0.76

The influence of heart rate on digoxin-induced inhibition of myocardial Na+-K+-ATPase activity in the dog. Clin Exp Pharmacol Physiol (1981) 0.76